Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2026-03-01 @ 9:58 AM
Study NCT ID:
NCT06553456
Status:
COMPLETED
Last Update Posted:
2025-09-30
First Post:
2024-08-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
Sponsor:
Protgen Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
rHSA 2020-3 (Phase Ⅲ)
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None